This message was sent to ##Email##
|
|
|
|
|
AST
The newly developed Travel for Techniques in Transplantation Research (T3R) Program supports the travel of a scientist to the laboratory of another scientist to acquire a new technique. This program fulfills a goal of the AST Research Network to facilitate bringing novel, cutting edge techniques to transplant biology research labs and clinical scientists. Recipients will receive up to $2,000 for travel. The deadline to apply is March 15, 2019.
READ MORE
AST
The AST values its members and consistently works to improve member experience. The AST is launching an improved Member Portal. Due to this transition, users will not have account access from Monday, Feb. 25–Tuesday, March 5.
READ MORE
AST
Join thousands of transplant professionals at this year's American Transplant Congress (ATC), June 1–5, 2019, in Boston, Massachusetts. From cutting-edge science that's transforming the field, to in-depth workshops and hot topic sessions, the ATC is quickly becoming the most recognized transplant Congress in the world.
READ MORE
 |
|
The Thompson Liver / Oncology System provides surgeons with the ability to obtain stable, versatile retraction for liver transplants, liver resections, oncology, and obesity cases. Multi-planed retraction and unlimited flexibility for the most complex abdominal and pelvic cases. Call 1-800-227-7543 to start your free trial.
|
|
OPTN/UNOS
OPTN/UNOS is offering nine proposals for public comment. You are encouraged to post comments on their website during the public comment period that runs January 22 – March 22, 2019. Your voice is important and considered during the OPTN/UNOS policy development process. During the public comment period, UNOS offers national webinars to provide members an opportunity to learn about proposals on the upcoming regional meeting agenda and ask questions of presenters/subject matter experts. For information about these webinars, click here.
The COPs will be reviewing the proposals and providing feedback for the AST's Policy Committee to develop a Society response for Board approval. If you would like to also submit your individual comments to AST for consideration as part of this process, please email them to scovington@myast.org with the subject line PUBLIC COMMENT.
|
The first and only clinically and analytically validated blood test that measures donor-derived cell-free DNA (dd-cfDNA), a direct indicator of kidney injury
Covered by Medicare
AlloSure 101 – Development & Summary Webinar – view
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
AST
As an AST member, access to free or discounted educational resources are included in your membership. These diverse educational resources offer materials relevant to the transplant professional in every stage of their career—from basic trainee lessons to webinars on specialized topics. LEARN MORE
AST
Transplant professionals have increasing demands on their time. Finding time in one's day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
|
|
| Upcoming Education Events
|
    |
AST
Geographic disparities in lung transplant rates
March 5, 2019 | 2 p.m. ET | Online Activity
For more information, click here.
Case-Based Multidisciplinary Approach to Cardiac and Pulmonary Vascular Disease Risk Assessment in Liver Transplantation
March 20, 2019 | 2 p.m. ET | Online Activity
For more information, click here.
APOL1 Genotype and Renal Function of Black Living Donors
March 28, 2019 | 2 p.m. ET | Online Activity
For more information, click here.
AST
The Thomas E. Starzl Transplantation Institute is accepting nominations for the 2020 Thomas E. Starzl Prize in Surgery and Immunology, awarded annually to a national or international leader in the field of organ transplantation and immunology. The prize consists of a crystal award, an honorarium of $10,000, and travel expenses to the University of Pittsburgh School of Medicine in the spring of 2020 to formally receive the award and to present the Thomas E. Starzl Prize in Surgery and Immunology lecture. The winner will also participate in related activities and meet informally with faculty, post-doctoral fellows and students.
READ MORE
ASTS
The goal of the ASTS Cellular Transplantation Committee is to advance the knowledge and promote clinical and research work in the field of cellular transplantation. One of this year’s initiatives that was set forward by the ASTS Cellular Transplantation Committee is to conduct the survey of ongoing research and clinical work in the areas of cellular products and therapies. The purpose of the project is to assess areas of interest of research within the transplant community. This survey should take approximately 10 minutes.
READ MORE
JAMA Network
What were the trends in use of liver grafts from older donors—aged 70 years and older—and outcomes in liver-only transplant recipients of older donor grafts in the United States from 2003 to 2016? In this cohort study, there was a decrease in the use of liver grafts from older donors despite significant improvements in all-cause graft loss and mortality among liver transplant recipients of older donor grafts.
READ MORE
Journal of Hepatology via ScienceDirect
Donation after circulatory death liver transplantation is known for potentially worse outcomes because of higher rates of graft non-function or irreversible cholangiopathy. The impact of machine liver perfusion techniques on these complications remains elusive. We aimed to provide data on 5-year outcomes in patients receiving DCD liver transplants, after donor organs had been treated by hypothermic oxygenated perfusion.
READ MORE
Journal of the American Society of Nephrology
Patients with ESRD experience a substantially increased incidence of cancer, but few studies have examined patterns of cancer mortality among such patients. This population-based cohort study of Australian patients who initiated dialysis or received a kidney transplant from 1980 to 2014 found that the risk of cancer-related death among patients on dialysis and kidney transplant recipients was 2.5 times higher than that of age- and sex-matched controls in the general population.
READ MORE
Journal of Nephrology via Springer Link
Due to the increasing occurrence of renal cell carcinoma in the general population and the high prevalence of chronic kidney disease among cancer patients, many people with a previous RCC may eventually require renal replacement therapy including kidney transplantation. They should accordingly be evaluated to assess their life expectancy and the risk that the chronic immunosuppressive therapy needed might impair their long-term outcome.
READ MORE
JAMA Network
For infants with biliary atresia, should biliary-enteric drainage remain the initial treatment of choice and liver transplant used as salvage therapy? In this cohort study that included 626 infants with biliary atresia, patients who underwent primary liver transplant had a markedly reduced risk of long-term mortality compared with patients initially managed with biliary-enteric drainage procedure.
READ MORE
|
The articles included in this email are for informational use only and are not endorsed by the AST.
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
